Characteristics

All

(N = 45)

BCL-2/Bax ratio

p-value

≤1.6 (N = 26)

>1.6 (N = 19)

No.

(%)

No.

(%)

No.

(%)

Age (years)

Mean ± SD

56.31

±12.3

56.19

±12.92

56.47

±11.55

0.927•

Median (Range)

54

(38 - 74)

53.50

(38 - 74)

54

(42 - 74)

≤60 years

25

(55.6%)

15

(60%)

10

(55%)

0.73

>60 years

20

(44.4%)

11

(55%)

9

(45%)

Sex

Male

26

(57.8%)

16

(61.5%)

10

(38.5%)

0.550

Female

19

(42.2%)

10

(52.6%)

9(47.4%)

Rai classification

Stages 0, 1 & 2

20

(44.4%)

17

(85%)

3

(15%)

0.001

Stages 3 & 4

25

(55.6%)

9

(36%)

16

(64%)

Hepatomegally

Absent

23

(51.1%)

13

(56.5%)

10

(43.5%)

0.862

Present

22

(48.9%)

13

(59.1%)

9

(40.9%)

Lymphadenopathy

Absent

14

(31.1%)

9

(64.3%)

5

(35.7%)

0.553

Present

31

(68.9%)

17

(54.8%)

14

(45.2%)

Spleenomegally

Absent

12

(26.7%)

11

(91.7%)

1

(8.3%)

0.006

Present

33

(73.3%)

15

(45.5%)

18

(54.5%)

WBCs (×10³/mm³)

Mean ± SD

46.80

±31.71

47.90

±37.22

45.30

±23

0.401•

Median (Range)

31.60

(17.50 - 122.80)

33.25

(17.50 - 122.80)

31.60

(17.50 - 112.50)

<100 × 10³/mm³

39

(86.7%)

21

(53.8%)

18

(46.2%)

0.222

≥100 × 10³/mm³

6

(13.3%)

5

(83.3%)

1

(16.7%)

Absolute lymphocytes (×10³/mm³)

Mean ± SD

26.27

±16.42

26.80

±17.42

25.55

±15.37

0.881•

Median (Range)

18

(9.10 - 67)

18.65

(9.10 - 67)

17.30

(13 - 67)

<30 × 10³/mm³

33

(73.3%)

19

(57.6%)

14

(42.4%)

0.964

≥30 × 10³/mm³

12

(26.7%)

7

(58.3%)

5

(41.7%)

Platelet count (×10³/mm³)

Mean ± SD

121.13

±47.20

134.69

±48.89

102.57

±38.69

0.035•

Median (Range)

111

(45 - 205)

125.50

(45 - 205)

90

(49 - 181)

<100 × 10³/mm³

19

(42.2%)

7

(36.8%)

12

(63.2%)

0.015

≥100 × 10³/mm³

26

(57.8%)

19

(73.1%)

7

(26.9%)